Natalizumab demonstrates a high response rate in patients with previously treated multiple sclerosis, improving or stabilizing the clinical course in the majority of cases, new findings suggest. Medscape Medical News
The 13-valent pneumococcal conjugate vaccine (PCV13) is as effective as the seven-valent vaccine against the original seven pneumococcal serotypes and should provide further protection against the six additional serotypes, a multicenter team reports. Reuters Health Information
If you are a current healthcare practitioner and have what you think are novel approaches to preventive medicine, US Surgeon General Regina Benjamin wants to hear from you. Medscape Medical News
